Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells
- PMID: 26096068
- DOI: 10.1002/path.4575
Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells
Abstract
Non-keratinizing nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. The EBV-encoded latent membrane protein 1 (LMP1) is believed to play an important role in NPC pathogenesis by virtue of its ability to activate multiple cell signalling pathways which collectively promote cell proliferation, transformation, angiogenesis, and invasiveness, as well as modulation of energy metabolism. In this study, we report that LMP1 increases cellular uptake of glucose and glutamine, enhances LDHA activity and lactate production, but reduces pyruvate kinase activity and pyruvate concentrations. LMP1 also increases the phosphorylation of PKM2, LDHA, and FGFR1, as well as the expression of PDHK1, FGFR1, c-Myc, and HIF-1α, regardless of oxygen availability. Collectively, these findings suggest that LMP1 promotes aerobic glycolysis. With respect to FGFR1 signalling, LMP1 not only increases FGFR1 expression, but also up-regulates FGF2, leading to constitutive activation of the FGFR1 signalling pathway. Furthermore, two inhibitors of FGFR1 (PD161570 and SU5402) attenuate LMP1-mediated aerobic glycolysis, cellular transformation (proliferation and anchorage-independent growth), cell migration, and invasion in nasopharyngeal epithelial cells, identifying FGFR1 signalling as a key pathway in LMP1-mediated growth transformation. Immunohistochemical staining revealed that high levels of phosphorylated FGFR1 are common in primary NPC specimens and that this correlated with the expression of LMP1. In addition, FGFR1 inhibitors suppress cell proliferation and anchorage-independent growth of NPC cells. Our current findings demonstrate that LMP1-mediated FGFR1 activation contributes to aerobic glycolysis and transformation of epithelial cells, thereby implicating FGF2/FGFR1 signalling activation in the EBV-driven pathogenesis of NPC.
Keywords: Epstein-Barr virus; FGFR1; LMP1; glycolysis; nasopharyngeal carcinoma.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.J Pathol. 2013 Jul;230(3):336-46. doi: 10.1002/path.4201. J Pathol. 2013. PMID: 23592276
-
LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.PLoS One. 2015 Aug 5;10(8):e0134896. doi: 10.1371/journal.pone.0134896. eCollection 2015. PLoS One. 2015. PMID: 26244812 Free PMC article.
-
Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.J Pathol. 2018 Oct;246(2):180-190. doi: 10.1002/path.5130. Epub 2018 Aug 22. J Pathol. 2018. PMID: 29968360 Free PMC article.
-
Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Expert Rev Mol Med. 2015 Aug 18;17:e15. doi: 10.1017/erm.2015.13. Expert Rev Mol Med. 2015. PMID: 26282825 Review.
-
EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.Adv Exp Med Biol. 2017;1018:75-90. doi: 10.1007/978-981-10-5765-6_6. Adv Exp Med Biol. 2017. PMID: 29052133 Review.
Cited by
-
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.EMBO Mol Med. 2020 Sep 7;12(9):e12050. doi: 10.15252/emmm.202012050. Epub 2020 Jul 12. EMBO Mol Med. 2020. PMID: 32657028 Free PMC article.
-
EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.Theranostics. 2023 Jan 1;13(2):458-471. doi: 10.7150/thno.78395. eCollection 2023. Theranostics. 2023. PMID: 36632221 Free PMC article.
-
Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells.Tumour Biol. 2016 Aug;37(8):10563-9. doi: 10.1007/s13277-016-4922-4. Epub 2016 Feb 8. Tumour Biol. 2016. PMID: 26857147
-
MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.Oncotarget. 2016 Aug 23;7(34):54838-54851. doi: 10.18632/oncotarget.10761. Oncotarget. 2016. PMID: 27458165 Free PMC article.
-
Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma.Mol Oncol. 2020 Dec;14(12):3234-3252. doi: 10.1002/1878-0261.12824. Epub 2020 Nov 8. Mol Oncol. 2020. PMID: 33064888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous